×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Lupin, Natco alliance to sell Tykerb

Lupin, Natco alliance to sell Tykerb
Comment E-mail Print Share
First Published: Thu, Jun 23 2011. 10 45 PM IST
Updated: Thu, Jun 23 2011. 10 45 PM IST
Mumbai: Local drug makers Lupin Ltd and Natco Pharma Ltd have jointly stated on Thursday that they will jointly develop and market a generic version of British drug maker Glaxo SmithKline Plc’s patented cancer drug Tykerb.
Glaxo posted sales of $113.6 million for this cancer drug, known as lapatinib ditosylate by chemical name, in March.
Hyderabad-based cancer specialty company Natco had already sought drug regulator’s approval for this generic drug by challenging Glaxo’s patent.
Comment E-mail Print Share
First Published: Thu, Jun 23 2011. 10 45 PM IST